Atovaquone, proguanil drug combination
Showing 9976 - 10000 of >10,000
Metastatic Colorectal Cancer Trial in United States (mFOLFOX6, MVA-BN-CV301, FPV-CV301)
Active, not recruiting
- Metastatic Colorectal Cancer
- mFOLFOX6
- +3 more
-
Duarte, California
- +6 more
Jan 18, 2023
Breast Cancer Trial in United States (Trastuzumab, Oxaliplatin)
Completed
- Breast Cancer
-
Bowling Green, Kentucky
- +6 more
Oct 13, 2021
Breast Cancer; HER2-positive; Metastatic Trial in Worldwide (Trastuzumab deruxtecan, Placebo, Taxane)
Recruiting
- Breast Cancer; HER2-positive; Metastatic
- Trastuzumab deruxtecan
- +4 more
-
Phoenix, Arizona
- +329 more
Jan 10, 2022
Merkel Cell Carcinoma Trial in United States (Avelumab, N-803, haNK™)
Terminated
- Merkel Cell Carcinoma
- Avelumab
- +2 more
-
San Francisco, California
- +4 more
Jan 7, 2022
Type2 Diabetes, MDD Trial in Maywood (Vortioxetine)
Withdrawn
- Type2 Diabetes
- Major Depressive Disorder
-
Maywood, IllinoisLoyola University Medical Center
Nov 22, 2022
Respiratory Disorder, Lung Infection Trial in France (Virtual reality headset)
Not yet recruiting
- Respiratory Disorder
- Lung Infection
- Virtual reality headset
-
Aix-en-Provence, France
- +3 more
Jul 26, 2023
Adverse Drug Reaction Trial in Worldwide (Pharmacogenomic testing)
Completed
- Adverse Drug Reaction
- Pharmacogenomic testing
-
Vienna, Austria
- +6 more
Apr 15, 2022
Covid19 Trial in New Fairfield (Famotidine 20 milligram tablet)
Withdrawn
- Covid19
- Famotidine 20 milligram tablet
-
New Fairfield, ConnecticutPykonsult headquarters
Dec 4, 2021
Metastatic Cancer, Renal Cancer Trial in Indianapolis, Columbus, Philadelphia (Atezolizumab, Bevacizumab, Entinostat)
Suspended
- Metastatic Cancer
- Renal Cancer
- Atezolizumab
- +2 more
-
Indianapolis, Indiana
- +3 more
Oct 29, 2022
Advanced Solid Tumors, Squamous Cell Carcinoma of the Head and Neck (SCCHN), Gastrointestinal (GI) Malignancies Trial in
Recruiting
- Advanced Solid Tumors
- +2 more
- INCA00186
- +2 more
-
Los Angeles, California
- +31 more
Jul 20, 2022
Erythropoietic Protoporphyria Trial in Worldwide (Afamelanotide, Placebo)
Completed
- Erythropoietic Protoporphyria
- Afamelanotide
- Placebo
-
Helsinki, Finland
- +7 more
Sep 16, 2021
Learn More About Long-Term Responses to Treatment With
Not yet recruiting
- Metastatic Colorectal Cancer
- Regorafenib (Stivarga, BAY73-4506)
-
Whippany, New JerseyBayer
Sep 1, 2023
Coronary Artery Disease With Myocardial Infarction Trial in Korea, Republic of (routine stress testing, No Routine stress
Completed
- Coronary Artery Disease With Myocardial Infarction
- routine stress testing
- No Routine stress testing
-
Chuncheon, Korea, Republic of
- +10 more
Apr 3, 2022
Rhegmatogenous Retinal Detachment, High-risk for Proliferative Vitreoretinopathy (PVR) Trial in Germany (5-fluorouracil and low
Completed
- Rhegmatogenous Retinal Detachment
- High-risk for Proliferative Vitreoretinopathy (PVR)
- 5-fluorouracil and low molecular weight heparin
- Placebo
-
Freiburg, BW, Germany
- +12 more
Apr 4, 2022
GVHD, Acute Trial (CYP-001 (Cymerus mesenchymoangioblast-derived mesenchymal stem cells; MCA-derived MSCs), Placebo,
Not yet recruiting
- Graft Versus Host Disease, Acute
- CYP-001 (Cymerus mesenchymoangioblast-derived mesenchymal stem cells; MCA-derived MSCs)
- +2 more
- (no location specified)
Dec 6, 2022
FimasaRtan-basEd BP Targets After Drug SwitcHing
Completed
- Essential Hypertension
-
Suwon, Korea, Republic ofAjou University Hospital
Dec 22, 2020
Squamous Cell Head Neck Cancer, Radiation Induced Xerostomia, Salivary Hypofunction Trial run by the (AAV2hAQP1)
Recruiting
- Squamous Cell Head and Neck Cancer
- +2 more
- AAV2hAQP1
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
May 3, 2022
Pharmacogenomic Testing Trial in Nashville (Educational video)
Recruiting
- Pharmacogenomic Testing
- Educational video
-
Nashville, Tennessee
- +1 more
Jul 15, 2022
Diabetic Neuropathies, Diabetes, Dietary Supplement Trial in Thessaloníki (Epineuron, Placebo group)
Completed
- Diabetic Neuropathies
- +2 more
- Epineuron
- Placebo group
-
Thessaloníki, Thessaloniki, GreeceUniversity General Hospital AHEPA
Aug 8, 2023
Anxiety Disorders,Generalized Anxiety Disorder Trial in United States (Escitalopram, Placebo)
Completed
- Anxiety Disorders,Generalized Anxiety Disorder
- Escitalopram
- Placebo
-
Dothan, Alabama
- +38 more
Sep 23, 2021
High Grade Astrocytic Tumor, Recurrent Glioblastoma, IDH-Wildtype, Recurrent Gliosarcoma Trial in Rochester (Biospecimen
Not yet recruiting
- High Grade Astrocytic Tumor
- +2 more
- Biospecimen Collection
- +2 more
-
Rochester, MinnesotaMayo Clinic
Jul 18, 2022
PCOS Trial in Swabi (dietary supplement, drug, combination product)
Recruiting
- PCOS
- Resveratrol
- +2 more
-
Swabi, Khyber Pukhtunkhwa, PakistanBacha Khan Medical Complex Swabi
Dec 15, 2022
Multiple Sclerosis, Relapsing-Remitting Trial in Chisinau (IMCY-0141, Placebo, Dimethyl Fumarate)
Recruiting
- Multiple Sclerosis, Relapsing-Remitting
- IMCY-0141
- +2 more
-
Chisinau, Moldova, Republic ofRepublican Clinical Hospital, ARENSIA Exploratory Medicine
Jun 8, 2022
Anti-emetic Drug Upon Combination Chemotherapy for Non-small
Completed
- Non-small Cell Lung Cancer
-
Otsu, Shiga, JapanShiga University of Medical Science Hospital
Aug 28, 2020